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3Abstract30
Bacteriocins produced by Lactobacillus salivarius isolates derived from31
gastrointestinal origin have previously demonstrated efficacy for in vivo protection32
against Listeria monocytogenes infection. In this study, comparative genomic analysis33
was employed to investigate the intraspecies diversity of seven L. salivarius isolates34
of human and porcine intestinal origin, based on the genome of the well characterised35
bacteriocin-producing strain L. salivarius UCC118. This revealed a highly conserved36
megaplasmid-encoded gene cluster in these strains involved in the regulation and37
secretion of two-component class IIb bacteriocins. However, considerable38
intraspecific variation was observed in the structural genes encoding the bacteriocin39
peptides. These ranged from close relatives of abp118 such as salivaricin P, which40
differs by 2 amino acids, to completely novel bacteriocins such as salivaricin T, which41
is characterized in this study. Salivaricin T inhibits closely related lactobacilli and42
bears little homology to previously characterized salivaricins. Interestingly, the two43
peptides responsible for salivaricin T activity, SalTα and SalTβ, share considerable44
identity with the component peptides of thermophilin 13, a bacteriocin produced by45
Streptococcus thermophilus. Furthermore, the salivaricin locus of strain DPC648846
also encodes an additional novel one-component class IId anti-listerial bacteriocin,47
salivaricin L. These findings suggest a high level of redundancy in the bacteriocins48
that can be produced by intestinal L. salivarius isolates using the same enzymatic49
production and export machinery. Such diversity may contribute to their ability to50
dominate and compete within the complex microbiota of the mammalian gut.51
4Introduction52
There is increasing evidence to suggest that bacteriocin production is a53
desirable probiotic trait which enables the establishment and persistence of the54
producing strains within the gastrointestinal tract (GIT) (2, 9, 15, 35). These55
antimicrobials may have a narrow or broad spectrum of inhibition (16). Although56
broad spectrum bacteriocins, such as nisin, have been useful with respect to the57
control of spoilage and pathogenic organisms in food preservation (8), there has been58
increasing interest in narrow spectrum bacteriocins, such as thuricin CD, due to their59
narrow specificity and minimal impact on non-target beneficial GIT microbes (30).60
As such, these bacteriocins offer potential alternatives to traditional antibiotics with61
respect to controlling pathogens within the gut (29). In situ production of such narrow62
spectrum bacteriocins by probiotics would overcome complications such as the63
proteolytic degradation of orally delivered antimicrobial peptides during gastric64
transit. Lactobacillus salivarius is a promising probiotic candidate frequently isolated65
from human, porcine and avian GITs, many of which are producers of unmodified66
bacteriocins of class IIa (pediocin-like bacteriocins), class IIb (two-component67
bacteriocins) and class IId (linear non-pediocin-like bacteriocins) (4, 13, 31).68
Significantly, an in vivo demonstration of the anti-infective properties of the abp118-69
producing strain L. salivarius UCC118 has established the in vivo functionality of70
such bacteriocins (6). In addition, purified OR7, a class IIa bacteriocin produced by71
the chicken intestinal isolate L. salivarius NRRL B-30514, has also been successfully72
employed to reduce Campylobacter jejuni colonization in poultry (31).73
Closely related variants of abp118 (a two-component class IIb bacteriocin)74
frequently occur in intestinally-derived L. salivarius from different hosts (2, 17, 26,75
27), suggesting that this feature may be important for the successful establishment of76
5L. salivarius within the GIT. Further evidence of the ecological advantage that this77
trait bestows upon the producing strains was provided by the salivaricin P-producing78
L. salivarius DPC6005, which prevailed over four components of a probiotic79
formulation within the porcine ileum (34). The production of analogous bacteriocins80
by genetically-distinct strains and species is frequently ascribed to extensive81
horizontal gene transfer events occurring within the GIT (1, 2, 15, 22, 33). It is thus82
notable that abp118 is encoded on a megaplasmid in L. salivarius UCC118. Although83
the transfer-associated genes within the conjugative megaplasmid pMP118 appear84
non-functional in L. salivarius UCC118 (10), corresponding RepA-type megaplasmids85
are universally present in L. salivarius (17). Interestingly, Wescombe et al., (2006)86
demonstrated the in vivo conjugative transmission of bacteriocin-rich megaplasmids87
in Streptococcus salivarius species, which was associated with the numerical88
prominence of the species within the oral cavity (35).89
The variable nature of L. salivarius with respect to their ability to produce90
bacteriocins, and the nature of the bacteriocins which they produce, is becoming91
increasingly apparent. It has been noted that many L. salivarius strains which harbour92
homologues of the abp118 structural genes do not display anti-Listeria activity (17).93
A recent comprehensive genomic analysis revealed that the three-component94
regulatory system responsible for the transcriptional regulation of abp118 production95
was not well conserved and was likely responsible for the bacteriocin negative96
phenotype of these strains (28). Other strains produce closely related, yet distinct,97
bacteriocins such as salivaricin P which differs from abp118 with respect to two98
amino acids in their respective β peptides (2). Interestingly, the nine associated99
polymorphisms (three in the αgene, six in the βgene) appear to be specific features100
associated with L. salivarius isolates derived from porcine intestinal origin (2). It101
6would thus seem that gene acquisition, mutation and/or gene decay, all of which are102
potential consequences of species adaptation to a specific ecological niche (3, 24),103
have impacted on the adaptation of this widespread bacteriocin locus of L. salivarius,104
driving genome-wide specialisation in response to a particular niche.105
We conducted a genome-wide comparison of seven genetically distinct106
bacteriocin-producing intestinal L. salivarius strains isolated in our laboratory which107
revealed that the salivaricin/abp118-associated bacteriocin locus is a site of high108
variability. In the case of the neonatal isolate L. salivarius DPC6488, two novel109
narrow spectrum bacteriocins, salivaricin T, which displays considerable homology to110
a two-component class IIb bacteriocin associated with Streptococcus thermophilus,111
and salivaricin L, a one component class IId bacteriocin exhibiting anti-Listeria112
activity, have been characterised in this study.113
7Materials and Methods114
Bacterial strains and culture conditions. L. salivarius strains of both human and115
porcine intestinal origin, previously isolated and characterised in our laboratory, were116
included in this study (Table 1). Lactobacilli were routinely cultured under anaerobic117
conditions at 37°C in MRS medium (Difco Laboratories, Detriot, MI). Anaerobic118
conditions were maintained with the use of anaerobic jars and Anaerocult A gas packs119
(Merck, Darmstadt, Germany). Listeria innocua DPC3572 and Listeria120
monocytogenes NCTC 11994 were grown aerobically at 37°C in BHI (Merck).121
122
Pulsed-field gel electrophoresis analysis. Differentiation of the L. salivarius isolates123
was confirmed by PFGE as previously described (23). The megaplasmid content of124
the strains was also determined by PFGE following S1 nuclease treatment of high-125
molecular-weight DNA, also previously described (17).126
127
DNA amplification, sequencing and analysis. Template DNA was extracted from L.128
salivarius DPC6005 and L. salivarius DPC6488 to amplify the genetic loci129
responsible for salivaricin production in the corresponding strains using primers130
designed specific to the locus of abp118 (accession number AF408405). A series of131
abp118-specific primers were used to amplify the salivaricin P locus of strain132
DPC6005 by routine PCR generating a contiguous sequence of approximately 13 kb.133
The primer pair 5’ CCGCCGATATACTATTCGTGG 3’ and 5’134
GAGAGTTAGACCTGATGAAG 3’ was also used to amplify the 13 kb salivaricin P135
gene cluster in its entirety using Extensor Hi-Fidelity PCR mastermix (Abgene,136
Surrey, UK) under conditions recommended by the manufacturer.137
8A PCR amplicon previously generated using DPC6488 template DNA and138
primers specific for the amplification of the salivaricin P structural genes (23)139
generated approximately 900 bp sequence data in the present study. Following140
sequence analysis, the abp118-specific primer pair above was also employed to141
amplify the 12 kb salivaricin gene cluster of strain DPC6488. Oligonucleotide primers142
were synthesised by Sigma-Genosys (Poole, Dorset, UK) and purified amplicons were143
sequenced by Beckman Coulter Genomics (Essex, UK). Alignments and analyses of144
sequence data were performed using LASERGENE 6 software (DNAStar Inc.,145
Madison, WI). Database searches were performed using the basic local alignment146
search tool (BLAST) on the National Centre for Biotechnology information (NCBI)147
server (http://www.ncbi.nlm.nih.gov). Open reading frames (ORFs) were identified148
using LASERGENE 6, ORF finder and glimmer on the NCBI server and Genemark,149
gene prediction software (http://exon.biology.gatech.edu).150
151
Microarray-based Comparative Genomic Hybridisation. Comparative genomic152
hybridizations were performed using a highly replicated custom microarray (Agilent153
Technologies, CA, USA) designed based on the genome of L. salivarius UCC118 as154
previously described (5, 11, 28). The experimental procedures for genomic DNA155
extraction, fragmentation and fluorescent labelling and co-hybridisation experiments156
of fluorescently-labelled gDNA of the test and reference strains employed in this157
study were recently described (28). Two-dye-swap replicate hybridisations were158
performed for each strain tested and self-hybridisation of the reference strain was159
carried out as a control experiment. Analysis of the microarray data were also as160
described by Raftis et al. (28). The sequencing data obtained for our strains was in161
agreement with the empirically determined cutoff intervals used to discriminate162
9between the presence, divergence and absence of genes previously selected on the163
basis of a comparison of the output data of a BLASTn comparison of the UCC118-164
specific oligonucleotide probe set with the sequence of the draft genome of the type165
strain Lactobacillus salivarius DSM20555 (accession number NZ_ACGT00000000)166
with the log2-transformed signal ratios determined for the hybridisation reaction of the167
gDNA of the corresponding strain (28). Therefore, these cuttoff intervals were also168
applied to the present dataset. Cutoff intervals of (≥ -1.5), (< -1.5, ≥ -2.4), (< -2.4, ≥ -169
4.5), (< -4.5, ≥ -5.8) and (< -5.8) corresponded to highly conserved, conserved,170
divergent, highly divergent, and absent features in the test strain relative to L.171
salivarius UCC118, respectively. Hierarchical clustering of strains was performed172
using the complete linkage clustering and results were visualised using Genesis173
software (32).174
175
Purification of the antimicrobial peptides produced by L. salivarius DPC6488.176
The antimicrobial peptides were purified from a 2 L overnight culture of L. salivarius177
DPC6488 grown in MRS media. The cells were harvested by centrifugation at 8,000178
× g for 15 min, resuspended in 250 mL 70% (vol/vol) propan-2-ol containing 0.1%179
(vol/vol) trifluoric acid (TFA) and stirred at room temperature for 3 h. Cells were180
removed by centrifugation, and propan-2-ol by rotary evaporation. The resultant181
preparation was applied to a 5.0 g (20 mL volume) Strata C18 solid phase extraction182
(SPE) column (Phenomenex, Cheshire, UK) pre-equilibrated with methanol and183
water. The column was washed with 35% (vol/vol) ethanol and the antimicrobial184
peptides were subsequently eluted with 70% (vol/vol) propan-2-ol containing 0.1%185
(vol/vol) TFA. Following removal of the propan-2-ol from the preparation, 4 ml186
aliquots were applied to a Jupiter proteo C12 reversed phase-high pressure liquid187
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chromatography (RP-HPLC) column (250.0 × 10.0 mm, 4 µm particle size, 90 Ǻ pore 188
size; Phenomenex) pre-equilibrated with 25% (vol/vol) acetonitrile 0.1% (vol/vol)189
TFA. The column was developed in a gradient of 25% to 55% (vol/vol) acetonitrile190
containing 0.1% (vol/vol) TFA from 5 to 50 min at a flow rate of 2.5 mL min-1.191
Individual fractions were assayed by well diffusion using the sensitive indicator strain192
L. bulgaricus LMG 6901, and matrix-assisted laser desorption ionisation-time of193
flight (MALDI-TOF) mass spectrometry (MS) was performed to determine fractions194
containing the peptides of interest. Fraction 27, containing a mass of 4433 Da195
corresponding to the salivaricin B peptide, was applied to a Luna analytical SCX196
cation exchange HPLC column (250.0 × 4.6 mm, 5 µm particle size, 100 Ǻ pore size; 197
Phenomenex), for further purification, following removal of acetonitrile by rotary198
evaporation. Using buffer A (20 mM potassium phosphate containing 25% (vol/vol)199
acetonitrile, pH 2.5), and buffer B (20 mM potassium phosphate, 25% (vol/vol)200
acetonitrile, 1 M potassium chloride, pH 2.5) the column was pre-equilibrated with201
10% buffer B and subsequently developed in a gradient of 10% to 65% buffer B, from202
5 to 45 min at a flow rate of 1.0 ml min-1. Individual fractions of interest were applied203
to a 200 mg (3 ml volume) Strata C18 SPE column (Phenomenex) pre-equilibrated204
with methanol and water. The column was washed with 30% (vol/vol) ethanol and205
40% (vol/vol) propan-2-ol, followed by the elution of the antimicrobial component206
with 70% (vol/vol) propan-2-ol containing 0.1% (vol/vol) TFA. Similarly, fractions207
38-40, containing masses of 5655 Da and 5267 Da corresponding to the respective208
SalTα and SalTβ peptides, were pooled, concentrated and applied to the Luna209
analytical SCX cation exchange HPLC column for separation and purification as210
described above, as were fractions 44-46, in which a mass of 4117 Da was detected211
corresponding to the mature salivaricin L peptide. Bacteriocin activity was monitored212
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throughout purification by well diffusion assay using the sensitive indicator strain L.213
bulgaricus LMG 6901. MALDI-TOF MS was performed as previously described (7).214
215
Peptide synthesis. Synthetic analogues of mature salivaricin B and salivaricin L were216
synthesised according to the deduced amino acid sequence of slnT3 and ORF13 (slnL)217
using microwave-assisted solid phase peptide synthesis (MW-SPPS) performed on a218
CEM LibertyTM microwave peptide synthesiser using a H-Ser-HMPB-ChemMatrix®219
and a H-Cys(TRT)-HMPB-ChemMatrix® resin (PCAS Biomatrix Inc. Quebec,220
Canada), respectively. The molecular masses of the synthetic analogues were221
confirmed using MALDI TOF MS and the antimicrobial activity of the crude peptides222
was assayed by well diffusion. Synthetic salivaricin L was purified by RP-HPLC223
using a Jupiter C5 column (250.0 × 10.0 mm, 10 µm particle size, 300 Ǻ pore size; 224
Phenomenex) developed in a gradient from 25% to 55% (vol/vol) acetonitrile225
containing 0.1% TFA from 10 to 50 min at a flow rate of 2.5 mL min-1. Fractions226
containing the desired molecular mass, identified by MALDI TOF MS, were pooled227
and lyophilised using a Genevac HT 4X lyophiliser (Genevac Ltd. Ipswitch, UK). The228
peptide was dissolved in 50% (vol/vol) acetonitrile at a concentration of 5 mg/ml and229
stored at -20°C under nitrogen. Appropriate dilutions of the peptides in 50mM230
potassium phosphate buffer pH 6.8 were used for bacteriocin assays.231
232
Specific activity analysis of salivaricin L. A microtiter plate assay system was used233
to determine the minimum concentration of the synthetic salivaricin L analogue234
required to inhibit growth of the indicators, L. innocua DPC3572 and L.235
monocytogenes NCTC 11994 by 50% (MIC50). The microtitre plate was first treated236
with bovine serum albumin (BSA) to prevent adherence of the peptide to the sides of237
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the wells, as described previously (12). Each plate included triplicate assays at each238
concentration examined. Each well contained a total volume of 200 µl, comprised of239
purified synthetic salivaricin L, 150 µl of a 1-in-10 dilution of the indicator culture240
(A590 of 0.5) in BHI broth. Control wells contained media only (blanks), or untreated241
indicator culture. The microtiter plate cultures were then incubated at 37°C and the242
optical density at 590 nm (OD590) recorded at hourly intervals for 6 h (GENios plus;243
TECAN, Switzerland). Triplicate readings were averaged and blanks were subtracted244
from these readings. The amount of bacteriocin that inhibited the indicator strain by245
50% was defined as 50% of the final OD590 ± 0.05 of the untreated control culture.246
247
Results248
The seven L. salivarius test strains included in this study were of either human or249
porcine intestinal origin (Table 1), and were specifically selected by their ability to250
produce bacteriocins which we propose constitutes an important probiotic trait (6, 31,251
34). For comparative reasons, one isolate of human origin with a bacteriocin negative252
phenotype, DPC6196, was also included in the genotypic analysis as it harbours253
homologues of the abp118 bacteriocin structural genes (2). Due to the localisation of254
the abp118 bacteriocin gene cluster on the megaplasmid of strain UCC118 (17), the255
megaplasmid content of the test strains was first compared with that of UCC118.256
257
Analysis of the megaplasmid content of bacteriocin-producing L. salivarius258
isolates. Pulsed field gel electrophoresis (PFGE) of total genomic DNA confirmed259
that the seven test strains were genetically distinct (data not shown), and the260
megaplasmid content of each, as determined by S1 PFGE, is outlined in Table 2. The261
human derived isolates DPC6196 and DPC6488 were found to harbour megaplasmids262
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of 180 and 195 kb, respectively. Smaller plasmids were also identified in these strains,263
two in DPC6488 of approximately 20 kb and 30 kb, and one in DPC6196 of264
approximately 48 kb. The porcine derived isolates, DPC6005, DPC6502 and 7.3, each265
contained megaplasmids of approximately 242 kb, similar to pMP118 (5), while266
DPC6027 and DPC6189 contained larger plasmids of 320 kb and 360 kb,267
respectively. Multiple megaplasmids were observed in L. salivarius DPC6189 and L.268
salivarius 7.3 which both appear to harbour an additional linear megaplasmid of269
approximately 195 kb. The linear nature of these megaplasmids was determined270
when, under different switching conditions, PFGE analyses revealed that the271
corresponding bands migrated to the same location on the gel regardless of whether272
DNA from these isolates was digested with S1 nuclease or not (data not shown).273
274
Genomic diversity of L. salivarius strains. Array comparative genomic hybridisation275
(aCGH) analyses revealed considerable genomic diversity between strain UCC118,276
the five Bac+ (bacteriocin-producing) porcine isolates and the human-derived Bac+277
strain DPC6488 and Bac- (bacteriocin negative, despite harbouring homologues of the278
abp118 structural genes) strain DPC6196, consistent with results reported by Raftis et279
al., (2011) (28). We particularly noted a high level of plasticity within the UCC118280
megaplasmid-associated bacteriocin abp118-encoding locus.281
282
Genetic diversity of the salivaricin bacteriocin locus in L. salivarius. The genetic283
determinants responsible for the production of abp118 are comprised of the abp118 α284
and β structural genes, accompanied by the genes encoding a cognate immunity285
protein, a three-component regulatory system, an ABC-transporter and transport286
accessory protein which are responsible for cleavage and secretion of the mature287
14
active bacteriocin (13) (Fig. 1). Six additional ORFs are also present on the 10.7 kb288
abp118 locus, three of which encode putative bacteriocin-like precursor peptides, two289
of which have no homologues while one was identified as a pre-salivaricin B290
homologue (4, 13). Each of the L. salivarius test isolates included in this study are291
bacteriocinogenic, with the exception of DPC6196, and sequence analysis revealed292
that the abp118 gene cluster shares greater than 90% sequence similarity with that of293
salivaricin P (data not shown (13)). Despite this, CGH revealed considerable genetic294
diversity with respect to the bacteriocin locus across the test strains (Fig. 2). The295
porcine intestinal strain DPC6502 was particularly notable by virtue of lacking296
abp118-related homologues, despite having an antimicrobial-producing phenotype297
(Fig. 2, (23)). This observation eliminates the possibility that this strain produces298
abp118, salivaricin P and/or salivaricin B. Although CGH data indicated that the299
bacteriocin structural genes, the genes encoding the response regulator and the300
transport system of abp118 were conserved in each of the remaining porcine derived301
isolates, DPC6005, DPC6027, DPC6189 and 7.3, the genes encoding the immunity,302
induction peptides and the histidine kinase component of the salivaricin regulatory303
system of these isolates were divergent from their respective abp118 counterparts, as304
illustrated in Fig. 2. Indeed, sequence analysis of the salivaricin P locus of the305
prototype producing strain DPC6005 (data not shown) confirmed this.306
Overall, the abp118 locus was most highly conserved in the human isolate307
DPC6196 (Fig. 2). Although displaying a Bac- phenotype, this isolate harbours308
homologues of abp118α and abp118β, differing by just 1 and 2 nucleotides,309
respectively (2). CGH analysis revealed divergence with respect to the abpT310
(LSL_1910) and abpD (LSL_1909) homologues, required for secretion of the mature311
active bacteriocin, in DPC6196 which is likely responsible for the Bac- phenotype of312
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this strain. Previously, PCR analysis using primers specific for the salivaricin P313
structural genes indicated the presence of related genes in L. salivarius DPC6488314
(23). However, the unique genetic variability pattern of this neonatal isolate instead315
indicated that the genes corresponding to abp118α (LSL_1917) and abp118β316
(LSL_1916) were divergent and absent, respectively (Fig. 2). In contrast, the genes317
encoding the abp118 regulatory and transport systems were perfectly conserved in this318
strain, relative to UCC118, as was the gene encoding pre-salivaricin B (LSL_1921).319
As this strain is of human origin, an important consideration in the selection of320
commercial probiotics, the antimicrobial activity and corresponding genetic321
determinants of this isolate were further investigated.322
323
Analysis of the gene products encoded by the salivaricin locus of L. salivarius324
DPC6488. A single primer pair successfully amplified the individual salivaricin loci325
of L. salivarius UCC118, DPC6005 and DPC6488 in their entirety. Sequencing of the326
corresponding amplicon of L. salivarius DPC6488 allowed for elucidation of the most327
divergent region of the bacteriocin locus of this strain, which on the basis of CGH328
data corresponds to the sequence between LSL_1913 and LSL_1924 of strain329
UCC118 (Fig. 2), and confirmed the conservation of the regulatory and transport330
systems of abp118 in this strain. In silico analysis of the sequence data resulted in the331
identification of 20 ORFs (Fig. 1; Table 3), five of which, ORF3-5, 7 and 13, encoded332
bacteriocin-like prepeptides. The putative products of ORF3 and ORF4333
(correspondingly designated slnT3 and slnT4) were 98% and 97% identical to the334
salivaricin B precursor peptide (LSL_1921) and a bacteriocin-like prepeptide335
(LSL_1918) of UCC118, respectively. The deduced products of ORF5 and ORF7 also336
resembled bacteriocin precursor peptides with double-glycine leader sequences, and337
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were designated slnTα and slnTβ (Fig. 3A). The first 57 nucleotides of slnTα closely338
resemble those encoding the leader peptide of Abp118α and Sln1, differing by two339
nucleotides (and, in turn, one aa) (Fig. 3B). However, no significant homology was340
observed between the corresponding propeptide (61 aa) and Abp118α (45 aa). Indeed341
a BLAST search revealed that this peptide instead shared 47% identity with ThmA,342
one component of the two-peptide bacteriocin thermophilin13 produced by343
Streptococcus thermophilus (20) (Fig. 3B). The bacteriocin-like precursor peptide344
encoded by slnTβ displayed similarity to acidocin LF221 A, one peptide of a putative345
two-component bacteriocin produced by Lactobacillus gasseri (18) (Fig. 3B). Only346
partial sequence of the complementary peptide of LF221 A (37 C-terminal aa) was347
available for comparison with the propeptide encoded by slnTα, with which it shared348
30% similarity (Fig. 3B). While the leader sequence of SalTβ also shares 42%349
similarity with that of Abp118α, no significant similarity was observed between the350
leader sequence of SalTβ and that of Abp118β (Fig. 3B). Indeed, the SalTβ leader351
sequence was most similar (59%) to that of the LafX peptide of lacticin F, produced352
by Lactobacillus johnsonii (Fig. 3B, (14)), while, perhaps most notably, the353
propeptide encoded by slnTβ shares 43% similarity with ThmB, the complementary354
peptide of ThmA (20).355
Further in silico analysis of this cluster identified two ORFs encoding putative356
immunity proteins downstream of the potential bacteriocin structural genes slnTα and357
slnTβ (Fig. 3A). The deduced protein sequences corresponding to slnT IM1 (ORF6)358
and slnT IM2 (ORF8) displayed 81% and 76% identity with Abp118 IM. Despite359
being present in two copies, these LSL_1915-homologues were not detected by CGH360
due to the divergence in the nucleotide sequences of the genes in DPC6488 (72% and361
69% identity, respectively, with abpIM). Three ORFs downstream of the putative362
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bacteriocin immunity gene, ORFs 9, 10 and 11, encode a putative induction peptide, a363
sensory transduction histidine kinase and a response regulator, which shared 100%,364
99% and 94% identity with their respective abp118 counterparts, thus confirming365
conservation of the regulatory system of abp118 in strain DPC6488. The deduced366
products of ORFs 12 and 14 did not share homology with any previously known367
proteins. The 59 aa putative bacteriocin prepeptide encoded by ORF 13 (slnL) consists368
of a double-glycine leader sequence of 18 aa and a mature peptide of 41 aa designated369
salivaricin L, and shared greatest homology (59% identity) with a putative bacteriocin370
precursor of the Streptococcus sp. C150 genome (accession no. EFX55741). This371
putative bacteriocin precursor also shared very weak homology (38% and 37%) with372
the precursor peptides of cerein 7B produced by Bacillus cereus Bc7 (25) and sakacin373
Q produced by Lactobacillus sakei (21), respectively. Interestingly, both cerein 7B374
and sakacin Q are single peptide class IId bacteriocins which are simultaneously375
produced with cerein 7A and sakacin P by their respective producing strains (21, 25).376
The deduced protein products of ORFs 15 and 16 share 99% and 97% identity with377
those involved in the transport of abp118, AbpT and AbpD, respectively, thus378
confirming conservation of the abp118 transport system in strain DPC6488. Three379
ORFs downstream of the putative bacteriocin transport genes encoded proteins380
homologous to the IS1223 family transposases. The protein products of overlapping381
ORFs 17 and 18 shared 97% and 94% identity with the 61 C-terminal aa and 246 N-382
terminal aa of transposase ISLasa2b encoded by LSL_1957, approximately 30 kb383
downstream of the abp118 bacteriocin locus on pMP118. In addition, the deduced384
product of ORF 19 shares 98% identity with transposase ISLasa1b encoded by385
LSL_1958 of L. salivarius UCC118, indicative of a possible recombination event.386
The final ORF identified on the salivaricin locus of DPC6488 encoded a hypothetical387
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protein of 274 aa, the C- and N-terminus of which shared 97% and 87% identity with388
the smaller hypotetical proteins encoded by LSL_1907 (174 aa) and LSL_1908 (76389
aa) of the abp118 locus, respectively.390
391
Isolation and characterisation of the bacteriocin-like peptides produced by L.392
salivarius DPC6488. The spectrum of activity of L. salivarius DPC6488, as393
determined by well diffusion assay of the neutralised cell free supernatant (CFS), was394
previously found to be limited to 12 closely related species of lactic acid bacteria395
(including Enterococcus, Lactobacillus and Streptococcus sp.) of a total of 62396
indicator strains investigated. This activity was lost upon protease treatment with397
proteinase K, α-chymotrypsin, trypsin or pepsin (23). Cross sensitivity assays using398
the CFS of DPC6488 and of the abp118 and salivaricin P producers (UCC118 and399
DPC6005, respectively) revealed that all 3 strains are immune to both abp118 and the400
DPC6488-associated antimicrobials. Interestingly, however, both human isolates were401
sensitive to the CFS of the salivaricin P producer DPC6005, despite the fact that their402
respective immunity peptides share greater than 76% sequence identity.403
Further investigations were performed to establish the nature of the404
antimicrobials produced by DPC6488. Mass spectral analysis revealed that peptides of405
mass corresponding to those of the mature products of slnT3, slnTα, slnTβ, and slnL406
were present in the culture supernatant of DPC6488. To determine if these peptides407
were responsible for the antimicrobial activity of the strain, the peptides were408
separated and purified using cation exchange chromatography. MS data confirmed the409
predicted molecular masses of the mature peptides encoded by slnTα, slnTβ, and slnL,410
5,655 Da, 5,269 Da, and 4,117 Da, respectively, in the individually eluted active411
fractions. The individual SalTα and SalTβ peptides exhibited antimicrobial activity412
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against the sensitive indicator strain L. delbrueckii ssp. bulgaricus LMG 6901, which413
was further enhanced when they were combined (Fig. 4). Thus slnTα and slnTβ414
appear to encode a two-peptide bacteriocin that most closely resembles thermophilin415
13, which we designated salivaricin T.416
MS analysis also established that the mature salivaricin B analogue encoded417
by salT3 is secreted by strain DPC6488 and identified the fraction containing a418
peptide of corresponding mass (4,433 Da). However, this peptide did not inhibit the L.419
delbreueckii ssp. bulgaricus indicator strain, nor did it display the anti-Listeria420
activity previously attributed to salivaricin B (4) (data not shown). As noted above, a421
gene encoding a homologue of the salivaricin B precursor peptide is also located on422
the abp118 gene cluster (LSL_1921) but was designated non-functional in L.423
salivarius UCC118 (5, 13). Indeed, CGH demonstrates that this gene is conserved in424
six of the seven test strains employed in this study and DNA sequence and MS data425
confirmed that the peptide encoded by slnT3 of DPC6488 shares 100% identity with426
salivaricin B. To investigate further, a synthetic analogue of mature salivaricin B was427
generated based on the deduced aa sequence of slnT3. However, we were again428
unable to detect antimicrobial activity from the synthetic peptide (data not shown).429
Furthermore when either the synthetic analogue or the purified salivaricin B-430
containing fraction were combined with those containing SalTα and SalTβ, or the431
individual purified component peptides of salivaricin P, Sln1 and Sln2, salivaricin B432
failed to enhance their antimicrobial activity against L. delbrueckii ssp. bulgaricus433
LMG 6901 or Listeria innocua (data not shown). These findings thus question the434
previously reported anti-Listeria potency of this bacteriocin (4).435
Interestingly, production of the fourth bacteriocin-like prepeptide encoded on436
the salivaricin gene cluster of strain DPC6488, with similarity to one-peptide class IId437
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bacteriocins, was also confirmed by MALDI-TOF MS. While this peptide inhibited438
three of the 12 indicator strains sensitive to salivaricin T, L. delbrueckii ssp.439
bulgaricus, L. delbrueckii ssp. lactis and L. ruminis, synergistic activity was not440
observed when combined with the salivaricin T component peptides SalTα and SalTβ.441
Moreover, the purified salivaricin L peptide also exhibited anti-Listeria activity. A442
synthetic analogue of the mature 41 aa peptide displaying similar activity to the443
natural peptide was employed to determine the specific activity of the bacteriocin,444
revealing an MIC50 of 20 µM for both L. innocua DPC3572 and L. monocytogenes445
NCTC 11994 (Fig. 5).446
Given the inactivity of salivaricin B, and the antimicrobial activity of purified447
SalTα, SalTβ and salivaricin L, it is apparent that the inhibition of L. delbrueckii ssp.448
bulgaricus LMG 6901 strain by L. salivarius DPC 6488 can be attributed to two novel449
bacteriocins encoded within a single gene cluster, which we designate salivaricin T,450
corresponding to the two component peptide products encoded by slnTα and slnTβ,451
and salivaricin L, corresponding to the one-peptide class IId bacteriocin encoded by452
salL. Furthermore, the regulatory and export systems of corresponding salivaricin453
locus are analogous to those of abp118 and salivaricin P, thereby highlighting the454
ability of these systems to recognise and produce various antimicrobial peptides.455
456
Discussion457
CGH analysis revealed a high level of intraspecies diversity within the intestinal L.458
salivarius isolates employed when compared to the genome of L. salivarius UCC118,459
largely consistent with a recent survey of the genomic diversity of 33 L. salivarius460
strains (28).461
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Bacteriocin production is a megaplasmid encoded feature of importance for462
the probiotic functionality of L. salivarius UCC118 (5, 6) and CGH confirmed the463
presence of repA-type megaplasmids in each of the test strains investigated in this464
study. The megaplasmids of DPC6488 and DPC6196 were considerably smaller in465
size than pMP118, notably, a 67 kb non-functional conjugation transfer locus present466
in UCC118 (10) is absent in these strains. Indeed, this locus is also absent in467
DPC6502 despite the fact that it harbours a megaplasmid similar in size to pMP118.468
This indicates a considerable number of additional megaplasmid-encoded features in469
DPC6502, which also is the case for DPC6027 and DPC6189 which harbour470
megaplasmids considerably larger than pMP118. CGH analysis of the bacteriocin471
locus in the porcine salivaricin P-producing test strain DPC6005 produced results472
which were consistent with subsequent sequence analysis. This revealed that the473
salivaricin P gene cluster was organised in a similar arrangement to the genetic locus474
of abp118 (13, 27), with the most notable difference between the genes encoding the475
induction peptides (60% identity). It was not surprising that the N-terminal region of476
the corresponding sensory histidine kinase genes also varied slightly (93% identity).477
Similar variations were previously observed between the regulatory operons of the pln478
loci of Lactobacillus plantarum C11 and L. plantarum NC8 which are also otherwise479
highly homologous (19). Indeed, similar levels of variability were observed with480
respect to the bacteriocin locus of all of the salivaricin P-producing porcine isolates,481
relative to UCC118, indicating that they may all be derived from a single ancestor.482
CGH also revealed that the bacteriocin-negative phenotype of the human isolate483
DPC6196 is likely due to a genetic defect in the bacteriocin transport system in this484
isolate.485
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Sequence analysis of the salivaricin locus of strain DPC6488 further validated486
the CGH data. Although the genes involved in regulation and transport of abp118487
were highly conserved in DPC6488, this strain harbours structural genes for the488
production of two novel antimicrobials, a two-component class IIb bacteriocin489
salivaricin T, and a one-peptide class IId bacteriocin salivaricin L. It is understandable490
that strain DPC6488 was previously mistakenly characterised as a salivaricin P491
producer as the primers designed to amplify the bacteriocin structural genes were492
complementary to the sequence encoding the double-glycine leader of Sln1 and the493
immunity genes of salivaricin P, which share considerable identity with the leader494
sequence of SalTα and the respective immunity genes of the corresponding salivaricin495
locus. Notably, the porcine isolate DPC6502, which was also previously characterised496
as a salivaricin-P producer, lacked all abp118-related homologues and so the Bac+497
phenotype of this strain will be the basis of further investigation.498
The leader sequence of the SalTα precursor is almost identical to that of the499
Abp118α and Sln1 prepeptides (95% identity, with just one conservative aa difference500
[I/V] in 19), which may be a requirement for the efficient processing and export of the501
mature active peptide by the conserved ABC transporter. Indeed, while the mature502
salivaricin T peptides most closely resembled the component peptides of thermophilin503
13 (20), the proteins involved in providing immunity to, regulating production of and504
transporting these peptides are analogous to those of abp118. However, it should be505
noted that, at present, the thermophilin 13 gene cluster has not been reported. The506
presence of two putative immunity genes downstream of each of the salivaricin T507
structural genes is interesting and this fact, combined with the individual activity of508
each of the component peptides, may indicate that salivaricin T evolved from two509
synergistically acting one-peptide bacteriocins. Interestingly, the one-peptide class IId510
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bacteriocins cerein 7B and sakacin Q with which salivaricin L shares weak homology511
are also simultaneously produced with cerein 7A and sakacin P by their respective512
producing strains B. cereus and L. sakei (21, 25). As observed with salivaricin T and513
salivaricin L, neither of these pairs of simultaneously produced bacteriocins exhibit514
synergistic activity. Moreover, salivaricin L exhibited antagonistic activity to the515
gastrointestinal pathogen L. monocytogenes, with an MIC50 of 20 µM.516
L. salivarius DPC6488 was selectively isolated from the neonatal faecal517
population as a consequence of its antimicrobial phenotype. Therefore, it is tempting518
to suggest that salivaricin T and salivaricin L production may be an important519
mechanism for host colonisation and prevalence of the producing strain allowing it to520
outcompete closely-related populations within the intestine. Notwithstanding this521
hypothesis, the apparent ability of L. salivarius to produce very differing bacteriocins522
using the same cellular machinery suggests a hitherto unknown versatility with523
respect to production of this dominant probiotic trait.524
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Figure legends664
Figure 1. Comparative representation of the abp118 and salivaricin T gene clusters.665
The bacteriocin structural and predicted immunity genes are indicated by the colours666
black and grey with a black outline, respectively. The homologues of the putative667
protein products encoded by the salivaricin T gene cluster are outlined in Table 3. The668
most notable regions of similarity between the respective structural and immunity669
genes are highlighted by the black dashed lines.670
671
Figure 2. Graphical representation of the genetic diversity of the bacteriocin locus672
within L. salivarius test strains as determined by aCGH. Black, blue and yellow673
regions represent absence, conservation or overrepresentation of CDS, respectively,674
corresponding to the colour legend.675
676
Figure 3. Nucleotide sequence and deduced peptide sequence of the salivaticin T677
structural genes and the immunity genes of salivaricin locus of L. salivarius678
DPC6488. (A) The 1087-bp DNA sequence shown encodes the component peptides679
of salivaricin T produced by L. salivarius 6488 (SalTα and SalTβ) together with their680
leader sequences (underlined). The GG-processing sites are indicated by bold681
triangles (▲). Two putative immunity genes are present downstream of slnTα and682
slnTβ. Putative ribosome binding sites (RBS), start and stop codons are indicated in683
bold, start codons are also underlined. An inverted repeat sequence (indicated by684
arrows) typical of a Rho-independent terminator sequence was identified downstream685
of slnTβ also indicated in bold. (B) Alignment of salivaricin T component precursor686
peptides with those of abp118, acidocin LF221 A, lactacin F, and thermophilin 13.687
The leader sequences of the Abp118α and SalTα prepeptides and SalTβ and LafX688
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prepeptides share 95% and 59% identity, respectively. The SalTα propeptide displays689
greatest identity (46%) with ThmA and their respective complementary peptides,690
SalTβ and ThmB share 33% identity. The SalTβ propeptide shares greatest identity691
(41%) with acidocin LF221 A, the partial available sequence of the LF221 A692
complementary peptide shares 24% identity with the propeptide of SalTα.693
694
Figure 4. MALDI-TOF MS data for purified SalTα and SlaTβ and individual and695
combined antimicrobial activity of SalTα and SlaTβ against L. delbrueckii subsp.696
bulgaricus LMG6901.697
698
Figure 5. Inhibitory effect of synthetic salivaricin L on the growth of indicator strains699
Listeria innocua DPC3572 (A), and Listeria monocytogenes NCTC 11994 (B) at700
concentrations of 0 µM (♦), 1.0 µM (), 5.0 µM (▲), 10.0 µM (○), 15.0 µM (×), 20.0701
µM (Δ) and 50.0 µM (◊). Error bars represent standard deviations based on triplicate702
data.703
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Table 1. Bacterial strains used in this study704
Source Strain Relevant features Reference
Lactobacillus delbrueckii subsp. bulgaricus LMG 6901 Indicator strain (2)
Listeria innocua DPC3572 Indicator strain (2)
Human Lactobacillus salivarius UCC118 Abp118 producer (13)
Lactobacillus salivarius DPC6196 Harbours bacteriocin structural genes (2)
Lactobacillus salivarius DPC6488 Produces salivaricin T and salivaricin L (23)
Porcine Lactobacillus salivarius DPC6502 Bacteriocin producer (23)
Lactobacillus salivarius 7.3 Salivaricin P producer (2)
Lactobacillus salivarius DPC6189 Salivaricin P producer (2)
Lactobacillus salivarius DPC6027 Salivaricin P producer (2)
Lactobacillus salivarius DPC6005 Salivaricin P producer (2)705
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Table 2. Megaplasmid content of intestinal L. salivarius strains706
Strain UCC118 DPC6196 DPC6488 DPC6502 DPC6027 DPC6189 7.3 DPC6005
Approximate length of circular megaplasmids (kb) 242 180 195 242 320 360 195 242
Additional plasmid content
Approximate length of linear megaplasmids (kb) - - - - - 195 195 -
Approximate length of smaller plasmids (kb) 44, 20 48 30, 20 - - - - -707
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Table 3. Homologues of the deduced proteins encoded by the salivaricin T bacteriocin locus of L. salivarius DPC6488708
ORF (gene) Size (aa) Function Homologue Identity (%)a Reference
ORF 1 (slnT1 ) 65 Conserved hypothetical protein Conserved hypothetical protein of L. salivarius DSM20555 95 [62/65] EEJ73426b
ORF 2 (slnT2 ) 87 Conserved hypothetical protein Conserved hypothetical protein of L. salivarius DSM20555 100 [87/87] EEJ73427b
ORF 3 (slnT3 ) 57 Bacteriocin-like prepeptide Salivaricin B prepeptide 98 [56/57] (4)
ORF 4 (slnT4 ) 89 Bacteriocin-like prepeptide LSL_1918 of L. salivarius UCC118 98 [83/85] (5)
ORF 5 (slnTα ) 80 Salivaricin T prepeptide SalT alpha ThmA, amphipathic pore-forming peptide precursor of S. thermophilus 45 [35/77] (20)
ORF 6 (slnT IM1 ) 59 Putative bacteriocin immunity protein Abp118 IM (LSL_1915) of L. salivarius UCC118 82 [45/55] (13)
ORF 7 (slnTβ ) 75 Salivaricin T prepeptide SalT beta Acidocin LF221A produced by L. gasseri 46 [31/67] (18)
ORF 8 (slnT IM2 ) 54 Putative bacteriocin immunity protein Abp118 IM (LSL_1915) of L. salivarius UCC118 76 [38/50] (13)
ORF 9 (slnT IP ) 38 Putative induction peptide Abp118 IP (LSL_1914) of L. salivarius UCC118 100 [38/38] (13)
ORF 10 (slnT K ) 429 Sensory transduction histidine kinase AbpK of L. salivarius UCC118 99 [424/429] (13)
ORF 11 (slnT R ) 265 Response regulator Salivaricin response regulator of strain CECT5713/ (AbpR 94%) 95 [249/263] ADJ79880b
ORF12 41 Hypothetical protein no homologues
ORF 13 (Sln L ) 59 Bacteriocin-like prepeptide Putative bacteriocin of Streptococcus sp. C105 60 [35/60] EFX55741b
ORF 14 74 Hypothetical protein no homologues
ORF 15 (slnT T ) 719 Salivaricin T ABC-transporter protein AbpT (LSL_1910) of L. salivarius UCC118 99 [709/719] (13)
ORF 16 (slnT D ) 384 Salivaricin T export accessory protein AbpD (LSL_1909) of L. salivarius UCC118 97 [370/384] (13)
ORF 17 63 Truncated transposase Transposase ISLasa2b, IS1223 family (LSL_1957) 97 [59/61] (5)
ORF 18 246 Truncated transposase Transposase ISLasa2b, IS1223 family (LSL_1957) 94 [231/246] (5)
ORF 19 172 Transposase IS1223 family transposase (LSL_1958, LSL_0049) of UCC118 98 [169/172] (5)
ORF 20 273 Hypothetical protein Conserved hypothetical protein of L. salivarius CECT5713 95 [257/270] ADJ79877b
aPercentage identity was determined using BLAST
bAccession number of sequence directly submitted to EMBL Database709
